NCT01341405View on ClinicalTrials.gov

Study of CG100649 Versus Celecoxib in Osteoarthritis Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

January 31, 2012

Conditions
Osteoarthritis
Interventions
DRUG

CG100649

once daily for 28 days

DRUG

Celecoxib

capsule, celecoxib 200 mg, once daily for 28 days

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

CrystalGenomics, Inc.

INDUSTRY